3-methylglutaconic acid has been researched along with Paraplegia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apter, N; Costeff, H; Divry, P; Elpeleg, O; Gadoth, N | 1 |
Al-Essa, M; Al-Shamsan, L; Bakheet, S; Ozand, PT; Patay, Z; Powe, J | 1 |
2 other study(ies) available for 3-methylglutaconic acid and Paraplegia
Article | Year |
---|---|
3-Methylglutaconic aciduria in "optic atrophy plus".
Topics: Adolescent; Adult; Ataxia; Child; Female; Glutarates; Humans; Male; Optic Atrophy; Paraplegia; Syndrome | 1993 |
18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
Topics: Brain; Brain Diseases; Child; Child, Preschool; Fluorodeoxyglucose F18; Glutarates; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Nervous System Diseases; Optic Atrophy; Paraplegia; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |